非侵入性整倍体胚胎选择:三种最有前景方法的前景与陷阱
本综述评估了三种用于IVF胚胎倍性评估的有前景技术:人工智能、非侵入性PGT-A和代谢组学。AI分类胚胎着床概率的平均AUC为0.7,优于形态学选择但劣于侵入性PGT-A。非侵入性PGT-A部分研究一致性可达100%,但多中心研究因母源污染一致性为78%;代谢组学最不成熟,初步数据显示与着床和PGT-A一致性>90%。
要点
- AI分类胚胎着床概率的平均AUC为0.7,优于形态学选择但劣于侵入性PGT-A。
- 非侵入性PGT-A部分研究一致性可达100%,但多中心研究因母源污染一致性为78%。
- 代谢组学初步数据显示与着床和PGT-A一致性>90%,但技术最不成熟。
核心结论
- AI是优于形态学选择但劣于侵入性PGT-A的选择方法。
- 非侵入性PGT-A已显著改进,若解决母源污染问题有潜力达到与PGT-A 100%一致,但>30%的整倍体胚胎从未着床。
- 代谢组学有潜力识别代谢上无法着床的整倍体胚胎。
- 两种或全部三种方法联合应用是可能的。
研究设计与样本
- 本综述优先纳入在≥50个周期中与囊胚活检一致性>80%的出版物。
主要发现
- AI分类胚胎着床概率的平均AUC为0.7。
- 部分非侵入性PGT-A研究与PGT-A一致性高达100%,但多中心研究因母源污染一致性为78%,可通过特定培养条件改变改善。
- 代谢组学初步数据显示与着床和PGT-A一致性>90%,且未改变培养条件。
- >30%的整倍体胚胎从未着床。
关键数值与推荐
- 优先纳入标准:与囊胚活检一致性>80%且在≥50个周期中验证。
- AI分类胚胎着床概率的平均AUC为0.7。
- 非侵入性PGT-A多中心研究一致性为78%。
- 代谢组学初步数据与着床和PGT-A一致性>90%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 非侵入性PGT-A存在母源污染问题,多中心研究一致性为78%。
- >30%的整倍体胚胎从未着床。
- 代谢组学是三种技术中最不成熟的。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The objective of this review was to evaluate the efficacy of three promising technologies for assessment of ploidy status in IVF embryos [i.e. preimplantation genetic testing for aneuploidy (PGT-A)]: artificial intelligence (AI), non-invasive PGT-A (niPGT-A) and metabolomics. Publications where >80% correlation with blastocyst biopsies could be demonstrated in ≥50 cycles were prioritized. AI was found to classify the chance of an embryo implanting with an average area under the curve (AUC) of 0.7. AI is thus a superior selection method compared with morphological selection alone, but is still inferior to invasive PGT-A. Some niPGT-A studies have up to 100% concordance with PGT-A, but a multicentre study showed 78% concordance due to maternal contamination, which can improve with specific changes in culture conditions. niPGT-A has thus improved significantly and has the potential to reach 100% with PGT-A if the issue of maternal contamination is solved; however, >30% of euploid embryos never implant. Finally, metabolomics is the least developed technique of the three, but some preliminary data show >90% concordance with implantation and with PGT-A without changing culture conditions. Metabolomics thus has the potential to identify euploid embryos that, metabolically, are incapable of implanting. A combination of two or all of these approaches is possible.
引用
- Munné S, Horcajadas JA, Seth-Smith ML, et al. Non-invasive selection for euploid embryos: prospects and pitfalls of the three most promising approaches. Reprod Biomed Online. 2025. PMID: 40934618. doi:10.1016/j.rbmo.2025.105077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。